3861 results for «297»

Filter By

3861 results

How should aortic stenosis be treated in the modern era and what is the role of the heart team?

15 Feb 2020 – From PCR Tokyo Valves 2020

Consult this session to gain insight into the current status of aortic stenosis treatment around the world, to learn more about the patient and treatment selection by the Heart Team, and to discover how the patient pathway's optimization may facilitate the increasing demand for TAVR.

How should aortic stenosis be treated in the modern era and what is the role of the heart team?

How to optimise coronary intervention therapy with SAPIEN 3

15 Feb 2020 – From PCR Tokyo Valves 2020

Consult this session to learn through various challenging cases about the optimal timing for performing coronary intervention for TAVI patients, the coronary access techniques for SAPIEN 3 patients and the differences in coronary access between balloon- and self-expandable devices.

How to optimise coronary intervention therapy with SAPIEN 3

Antithrombotic therapy for AF in bioprosthetic valve

15 Feb 2020 – From PCR Tokyo Valves 2020

Consult this session to learn more about the anticoagulant therapy for bioprosthetic valves with AF, the optimal stroke prevention strategy after TAVI and the clinical impact of the current data on leaflet thrombosis.

Antithrombotic therapy for AF in bioprosthetic valve

Valve selection for patients with longer life

15 Feb 2020 – From PCR Tokyo Valves 2020

Consult this session to learn more about patients with failed surgical bioprosthesis valves' treatment, valve selection impacts clinical and procedural outcomes, and discover some future trends in treating TAVI patients with longer life expectancy which may revolutionize your practice.

Valve selection for patients with longer life

TAVI as cutting edge

16 Feb 2020 – From PCR Tokyo Valves 2020

Consult this session to learn all about LOTUS Edge's current status, long term outcome in japan, and clinical use thanks to a selection of challenging cases.

TAVI as cutting edge

Beyond the evolution! Latest image guided therapy for structural heart disease intervention 2.0 era

16 Feb 2020 – From PCR Tokyo Valves 2020

Consult this session in japanese to learn more about EchoNavigator, an innovative tool for guidance of interventional procedures in structural heart disease, and discover how it may help you achieve a better patient outcome.

Beyond the evolution!  Latest image guided therapy for structural heart disease intervention 2.0 era

Primary mitral regurgitation in 2019: how to deliver the best treatment to our patients

05 Dec 2019 – From PCR London Valves 2019

Consult this session on primary mitral regurgitation to learn more about the current practice and advanced surgical and transcatheter techniques, and discover key tips and tricks that will improve procedural outcomes in your everyday clinical practice.

Primary mitral regurgitation in 2019: how to deliver the best treatment to our patients

TAVI in bicuspid aortic valve disease - Session with LIVE case

19 Nov 2019 – From PCR London Valves 2019

Watch this session with LIVE demonstration from Clinique Pasteur - Toulouse, France

TAVI in bicuspid aortic

Case-based learning for the Heart Valve team: TAVI failure - What are the options?

19 Nov 2019 – From PCR London Valves 2019

Consult this session to learn more about the detection and management of structural valve deterioration and bioprosthetic valve failure, and discover the key role of imaging in patient assessment, with a selection of challenging clinical cases: a TAVI patient with structural valve deterioration, another one with infective endocarditis, and more!

Case-based learning for the Heart Valve team: TAVI failure - What are the options?

Secondary mitral regurgitation in 2019: mastering the full spectrum of treatment options

19 Nov 2019 – From PCR London Valves 2019

Consult this session on secondary mitral regurgitation to update your knowledge regarding the contemporary evidence base for its management, and learn more about the complexity and variability of clinical presentation and the spectrum of therapeutic options, thanks to a selection of studies and clinical cases.

Secondary mitral regurgitation in 2019: mastering the full spectrum of treatment options

Complex and challenging cases I

18 Dec 2019 – From GulfPCR-GIM 2019

Consult this session to learn how to manage complex complications, with a selection of challenging clinical cases such as: high-risk left main artery, stent ablation and rota-stenting, LT main lesion, and more!

Complex and challenging cases I

My five top trials in interventional cardiology in 2019: impact on clinical practice?

02 Jan 2020 – From GulfPCR-GIM 2020

Consult this session to learn all about the latest evidence from trials relevant for interventional cardiology, selected by EAPCI President Andreas Baumbach, and discover their impact on your daily practice: COMPLETE, BIOSTEMI, EXCEL, and more!

My five top trials in interventional cardiology in 2019 and their impact on clinical practice

Complex and challenging cases II

19 Dec 2019 – From GulfPCR-GIM 2019

Consult this session to discover how to safely manage difficult complications, thanks to a selection of complex clinical cases: ascending aortic dissection, balloon rupture, retrograde PCI on CTO of ostial right coronary artery, and more!

Complex and challenging cases II

GulfPCR-GIM 2019 Award and Closing Ceremony

19 Dec 2019 – From GulfPCR-GIM 2019

Consult this session to see the slides presented during GulfPCR-GIM 2019 Award and Closing Ceremony, which gathered 832 active participants, and discover who the best clinical case award winner was that year.

GulfPCR-GIM 2019 Award and Closing Ceremony

Clinical benefits of co-registration IVUS, FFR and iFR pullback in daily PCI

18 Dec 2019 – From GulfPCR-GIM 2019

Consult this session to learn how to use IVUS to guide vessel preparation and size stents and assess angioplasty results, how SyncVision IVUS co-registration can improve efficiency of angioplasty, and how iFR co-registration can guide angioplasty in patients with diffuse disease.

Clinical benefits of co-registration IVUS, FFR and iFR pullback in daily PCI

PCI optimisation: OCT and physiology in a complex multivessel disease case

18 Dec 2019 – From GulfPCR-GIM 2019

The patient is a 57-year-old male with high-risk factors and previous history of revascularisation. He presents with ischemic chest pain with NSTE-ACS. The baseline angiography shows multivessel disease and calcified LAD/D1 bifurcation (1,1,0).

The key objectives of this case are:

  1. Utility of FFR in physiological assessment of a...
PCI optimisation: OCT and physiology in a complex multivessel disease case

PCR Tokyo Valves 2020: Selection of the 2020 best clinical cases

16 Feb 2020 – From PCR Tokyo Valves 2020

Consult this session to discover a selection of the best clinical cases presented during PCR Tokyo Valves 2020: unusual cause of coronary artery obstruction after TAVI, simultaneous TAVR-in-TAVR and valve-in-mitral-annular-calcification intervention, paravalvular leak with valve-in-valve TAVR and bioprosthetic ring fracturing, and more!

Selection of the 2020 best clinical cases

Shared decision making in low-risk patients with aortic stenosis

16 Feb 2020 – From PCR Tokyo Valves 2020

Consult this session to discover how the concept of low-risk applies in Asian clinical practice, what is the impact of the TAVI low-risk trials on the management of individual patients, and learn more about the future role of the Heart Team.

Shared decision making in low-risk patients with aortic stenosis

PCR Tokyo Valves 2020: Selection of the best abstracts

16 Feb 2020 – From PCR Tokyo Valves 2020

Consult this session to discover a selection of the best abstracts submitted at PCR Tokyo Valves 2020: the efficacy of direct visualization of MANTA using ultrasound-navigated technique following large-bore arteriotomy, inflammatory reaction associated with leaflet thrombosis in the transcatheter aortic valve, and more!

Selection of the 2020 best abstracts

Strategies to handle complications during interventions for structural heart disease: my worst nightmare - Part 1

16 Feb 2020 – From PCR Tokyo Valves 2020

Consult this session to learn all about how to handle and avoid complications during interventions for structural heart disease, such as TAVI valve emboli, intra-aortic balloon occlusion, mitral leaflet tear, and more!

Strategies to handle complications during interventions for structural heart disease
Didn’t find what you were looking for?